Rabeprazole Sodium
- Product NDC
- 70934-403
- 11-digit product format
- 709340403
- Labeler code
- 70934
- Product ID
- 70934-403_adb91b0c-25bd-5626-e053-2a95a90ac5bd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rabeprazole Sodium
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA208644
- Marketing category
- ANDA
- Marketing start
- 2019-07-08
- Marketing end
- 0000-00-00
- Substance
- RABEPRAZOLE SODIUM
- Active strength
- 20 mg/1
- Pharmacologic classes
- Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-403-60 | 70934040360 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (70934-403-60) | 2019-07-08 | 0000-00-00 | No | No | Current |